Xenetic Biosciences Inc (NASDAQ:XBIO)

1.64
Delayed Data
As of Jun 15
 +0.0248 / +1.54%
Today’s Change
1.37
Today|||52-Week Range
4.49
-14.52%
Year-to-Date
No recent news for Xenetic Biosciences Inc.

Today’s Trading

Previous close1.62
Today’s open1.64
Day’s range1.64 - 1.64
Volume750
Average volume (3 months)11,134
Market cap$16.1M
Data as of 3:53pm ET, 06/15/2018

Growth & Valuation

Earnings growth (last year)+94.77%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+152.83%
P/E ratioNM
Price/Sales2.19
Price/Book1.13

Competitors

 Today’s
change
Today’s
% change
CTXRCitius Pharmaceutica...+0.02+0.75%
AOXGAoxing Pharmaceutica...0.000.00%
CLRBCellectar Bioscience...+0.02+2.14%
PRANPrana Biotechnology ...-0.06-3.00%
Data as of 4:00pm ET, 06/15/2018

Financials

Last reporting dateFebruary 28, 2018
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$7.6M
Annual profit (last year)-$3.6M
Net profit margin-47.40%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive &
Operating Officer, Director
Jeffrey F. Eisenberg
CFO, Principal Accounting Officer &
Secretary
James F. Parslow
Corporate headquarters
Lexington, Massachusetts

Forecasts